Reslizumab successfully treats case of NEAE after COVID-19 vaccination
A 70-year-old woman diagnosed with non-episodic angioedema associated with eosinophilia (NEAE) — high levels of immune eosinophil cells — was successfully treated with reslizumab, a medication normally used to treat asthma associated with eosinophilia, according to a case report. Her symptoms had started after receiving a…